Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-009 · Classification

B12-08: Pernicious anemia evaluation

Pernicious anemia evaluation. Evaluates low or borderline B12.

Active rulePriority 4B12 engine v1.0.0

Condition

  • low or borderline B12
  • age 60 and over, OR autoimmune disease (type 1 diabetes, autoimmune thyroid disease, vitiligo, Addison disease), OR glossitis

What it reports

  • Autoimmune gastritis (pernicious anemia) is a leading cause: intrinsic-factor antibodies are specific when positive

Recommended next steps (for physician review)

  • Consider intrinsic-factor antibodies
  • If positive, pernicious anemia is supported and its gastric implications should be considered by the physician

Diagnostic boundary

  • Negative antibodies do not exclude pernicious anemia.

Evidence

  • EV-BSH-2014Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496-513.Supports: Diagnostic approach with serum B12, MMA and homocysteine Neurologic involvement means treatment should not wait for confirmation Folic acid alone must not be given while B12 deficiency is unexcluded
  • EV-GREEN-2017Green R, Allen LH, Bjørke-Monsen AL, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040.Supports: Functional deficiency, markers (MMA, homocysteine) and causes including autoimmune gastritis

Cases where this rule fires

Open a case to see this rule fire with real inputs, then change the values until it stops.

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod